Summary
The urinary free cortisol (UFC) output, considered a parameter of the action of the exogenous corticosteroid on the hypothalamo-pituitary axis, was followed in five patients who received a total of 12 intra-articular (i.a.) injections of 40 mg of triamcinolone acetonide (TCA) distributed over eight treatment sessions. The effect of intra-articular TCA injections on UFC output was null after three treatment sessions, transient (48 hr) after another three, and more prolonged (6 days), although slight, after the remaining two sessions. These results contrast with the lasting and profound inhibition of the UFC output induced either by the same TCA dose given intramuscularly, or by oral administration of dexamethasone to 30 normal subjects, 0.75 mg at 8-hourly periods for 48 hours.
Adrenocortical reactivity, as measured by the response to synthetic ACTH (tetracosactrin) of both plasma cortisol levels and UFC output, was studied in another five patients prior to and after eight i.a. injections of 40 mg of TCA, and in three patients after six i.a. injections of 25–100 mg of hydrocortisone acetate. No decrease was observed after the i.a. injections of HCA. Considered as a group the response to tetracosactrin after TCA injections was not significantly altered. Two patients showed a decreased response of both UFC and plasma cortisol, although their values remained within the limits of those obtained in 44 normal control subjects. In contrast, profound inhibition of the tetracosactrin induced response occurred in a control group of 30 sujects given 0.75 mg of dexamethasone orally at 8-hourly periods for 48 hours.
Similar content being viewed by others
References
Dixon A.St.J., Bywaters E.G.L., The effect of intra-articular injection of cortisone acetate and of hydrocortisone acetate in rheumatoid arthritis. Clin. Sci. 1953, 12, 15–31.
Holden G., Kendall P.H., The newer corticosteroids for local injection. Ann. Phys. Med. 1961, 6, 178–182.
Louyot P., Gaucher A., Essais thérapeutiques d'une préparation corticoïde injectable (acétate de paraméthasone). Ann. Méd. Nancy 1966, 5, 1023–1032.
Astorga, G., Rossi G., Campodonico M., Munoz A., Estudio de los effectos locales y sistemicos de la hexacetonida de triamcinolona administrada por via intraarticular. Rev. Méd. Chile 1970, 98, 610–615.
Oliver C., Lapousse J.C., Maestracci D., d'Omezon Y., Vague P., Hawthorn E., Retentissement de la corticothérapie intra-articulaire et intrarachidienne sur l'axe hypophyso-surrénal. Rhumatologie 1971, 23, 323–330.
Shuster S., Williams I.A., Adrenal suppression due to intra-articular corticosteroid therapy. Lancet 1961, 2, 171–172.
Bain L.S., Jacomb R.G., Wynn V., Parenteral administration of 6 a-methylprednisolone-21-acetate. Part II: absorption and duration of effect. Ann. Phys. Med. 1967, 9, 49–54.
Rausch-Stroomann J.G., Petry R., Brandt T., Thomas E., Vergleichende Untersuchungen über die intramuskuläre und intraartikuläre Anwendung des Depot-Steroidpräparates Triamcinolon-Acetonid. Arzneimittel-Forsch. 1971, 21, 836–840.
Esselinckx W., Bacon P.A., Ring E.F.J., Crooke D., Collins A.J., Demottaz D., A thermographic assessment of three intra-articular prednisolone analogues given in rheumatoid synovitis. Br. J. Clin. Pharmacol. 1978, 5, 447–451.
Bird H.A., Ring E.F.J., Bacon P.A., A thermographic and clinical comparison of three intra-articular steroid preparations in rheumatoid arthritis. Ann. Rheum. Dis.1979, 38, 36–39.
Reeback J.S., Chakraborty J., English J., Gibson T., Marks V., Plasma steroid levels after intra-articular injection of prednisolone acetate in patients with rheumatoid arthritis. Ann. Rheum. Dis. 1980, 39, 22–24.
Armstrong R.D., English J., Gibson T., Chakraborty J., Marks V., Serum methylprednisolone levels following intra-articular injection of methylprednisolone acetate. Ann. Rheum. Dis. 1981, 40, 571–574.
Murphy B.E.P., Some studies of the protein-binding of steroids and their application to the routine micro and ultramicro measurement of various steroids in body fluids of competitive protein-bindingradioassay. J. Clin. Endocr. 1967, 27, 973–990.
Kolanowski J., Réponse du cortex surrénal à la corticotropine chez l'individu normal. Arch. Int. Pharmacodyn. Ther. 1970, 185, 196–199.
Kolanowski J., Esselinckx W., Nagant de Deuxchaisnes C., Crabbe J., Adrenocortical response upon repeated stimulation with corticotrophin in patients lacking endogenous corticotrophin secretion. Acta Endocrinol., 1977, 85, 597–607.
Kolanowski J., Pizarro M.A., Critical evaluation of competitive protein-binding radioassay for cortisol. Ann. Endocr. (Paris) 1969, 30, 177–182.
Williams P.L., Crawley J.C.W., Freeman A.M., Lloyd D.C., Gumpel J.M., Feasibility of outpatient management after intra-articular yttrium-90: comparison of two regimens. Br. Med. J. 1981, i, 986–987.
Zacco M., Richardson E.M., Crittenden J.C., Hollander J.L., Dohan F.C., Disposition of intra-articularly injected hydrocortisone acetate, hydrocortisone and cortisone acetate in arthritis. I. Concentrations in synovial fluid and cells. J. Clin. Endocr. 1954, 14, 711–718.
Winter J.A., Sandberg A.A., Saroff J., Slaunwhite W.R., Disposition and metabolism of intra-articularly injected 4-C14-cortisol in rheumatoid arthritis. Arthritis Rheum. 1967, 10, 352–356.
Oka M., Absorption of acetates of hydrocortisone, Δ1-hydrocortisone and cortisone from the joint cavity into the circulation. J. Clin. Endocr. 1958, 18, 755–763.
Laaksonen A.L., Sunell J.E., Westeren H., Mulder J., Adrenocortical function in children with juvenile rheumatoid arthritis and other connective tissue disorders. Scand. J. Rheumatol. 1974, 3, 137–144.
Koehler B.E., Urowitz M.B., Killinger D.W., The systemic effects of intra-articular corticosteroid. J. Rheumatol. 1974, 1, 117–125.
Esselinckx W., Nagant de Deuxchaisnes C., Données pharmacologiques et physiologiques concernant les corticostéroïdes et l'ACTH. Application à l'usage clinique. Louvain Méd. 1975, 94, 243–276.
Jacobs H.S., Nabarro J.D.N., Tests of hypothalamic-pituitary-adrenal function in man. Q.J. Med. 1969, 38, 475–492.
Jasani M.K., Boyle J.A., Greig W.R., Dalakos T.G., Brouwning M.C.K., Thompson A., Buchanan W.W., Corticosteroid-induced suppression of the hypothalamopituitary-adrenal axis: observations on patients given oral corticosteroids for rheumatoid arthritis. Q.J. Med. 1967, 36, 261–276.
Sampson P.A., Winstone N.E., Brooke B.N., Adrenal function in surgical patients after steroid therapy. Lancet 1962, 2, 322–325.
Kehlet H., Binder C., Value of an ACTH test in assessing hypothalamic-pituitary-adrenocortical function in glucocorticoid-treated patients. Br. Med. J. 1973, 2, 147–149.
Kehlet H., Blichert-Toft M., Lindholm J., Rasmussen P., Short ACTH test in assessing hypothalamic-pituitary-adrenocortical function. Br. Med. J. 1976, 1, 249–251.
Wynn V., The assessment of hypothalamic-pituitary-adrenocortical function in man. Mem. Soc. Endocrin. 1968, 17, 213–236.
Plumpton F.S., Besser G.M., The adrenocortical response to surgery and insulin-induced hypoglycaemia in corticosteroid-treated and normal subjects. Br. J. Surg. 1969, 56, 216–219.
Plumpton F.S., Besser G.M., Cole P.V., Corticosteroid treatment and surgery. 1. An investigation of the indications for steroid cover. 2. The management of steroid cover. Anaesthesia 1969, 24, 3–12.
Cope C.L., Black E.G., The reliability of some adrenal function tests. Br. Med. J. 1959, 4, 1117–1122.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Esselinckx, W., Kolanowski, J. & de Deuxchaisnes, C.N. Adrenocortical function and responsiveness to tetracosactrin infusions after intra-articular treatment with triamcinolone acetonide and hydrocortisone acetate. Clin Rheumatol 1, 176–184 (1982). https://doi.org/10.1007/BF02042771
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02042771